These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35871777)

  • 21. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
    Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Expression of
    Deng H; Huang Y; Wang L; Chen M
    Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying the Antitumor Effects of Curcumin on Lung Adenocarcinoma Using Comprehensive Bioinformatics Analysis.
    Yang FR; Li SY; Hu XW; Li XR; Li HJ
    Drug Des Devel Ther; 2022; 16():2365-2382. PubMed ID: 35910781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncovering the pharmacological mechanism of Wei-Tong-Xin against gastric ulcer based on network pharmacology combined with in vivo experiment validation.
    Liu W; Zhang X; Ma T; Wang J; Lv X; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2022 Jul; 293():115282. PubMed ID: 35405254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study on the mechanism of Cortex Lycii on lung cancer based on network pharmacology combined with experimental validation.
    Guo Z; Yin H; Wu T; Wu S; Liu L; Zhang L; He Y; Zhang R; Liu N
    J Ethnopharmacol; 2022 Jul; 293():115280. PubMed ID: 35405252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated Network Pharmacology Analysis and Experimental Validation to Investigate the Molecular Mechanism of Triptolide in the Treatment of Membranous Nephropathy.
    Zhang PN; Tang JY; Yang KZ; Zheng QY; Dong ZC; Geng YL; Liu YN; Liu WJ
    Drug Des Devel Ther; 2022; 16():4061-4076. PubMed ID: 36448035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway.
    Chen X; Zhang W; Xu X
    World J Surg Oncol; 2021 Aug; 19(1):232. PubMed ID: 34362378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation.
    Zhuang Z; Lin T; Luo L; Zhou W; Wen J; Huang H; Liu Z; Lin L
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33506873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of Tetrandrine Against Endometrial Cancer Based on Network Pharmacology.
    Shang W; Zhang J; Song H; Zhu S; Zhang A; Hua Y; Han S; Fu Y
    Drug Des Devel Ther; 2021; 15():2907-2919. PubMed ID: 34262258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
    Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
    J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
    Li JL; Hou W
    Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis.
    Liu J; Liu J; Tong X; Peng W; Wei S; Sun T; Wang Y; Zhang B; Li W
    Drug Des Devel Ther; 2021; 15():3255-3276. PubMed ID: 34349502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
    Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
    Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses.
    Zhang K; Wang K; Zhang C; Teng X; Li D; Chen M
    BMC Cancer; 2022 Jun; 22(1):687. PubMed ID: 35733175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
    Liu H; Li X; Duan Y; Xie JB; Piao XL
    J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.